发明名称 TRANSPLANTATION AGENT FOR HEMATOPOIETIC STEM CELL
摘要 <p>PROBLEM TO BE SOLVED: To obtain the subject agent by including hematopoietic stem cells as an active ingredient so as to transplant donor-derived hematopoietic stem cells through portal injection and settle the problem of take-failure/rejection after a specified pretreatment for the transplantation SOLUTION: The hematopoietic stem cells are transplanted through portal injection after pretreatment for transplantation with an effective amount of irradiation for transplantation of hematopoietic stem cells as an effective ingredient and preferably the cells are also transplanted through intravenous injection in addition. The above-mentioned irradiation is preferably performed in two portions a day by whole body irradiation as a treatment for autoimmune disease and the above-mentioned hematopoietic stem cells are preferably such as bone marrow cells containing 1-2% T cells or the like.</p>
申请公布号 JPH11343242(A) 申请公布日期 1999.12.14
申请号 JP19990058942 申请日期 1999.03.05
申请人 OTSUKA PHARMACEUT CO LTD 发明人 IKEHARA SUSUMU;INABA MUNEO;TAKEUCHI KENJI;KUSHIDA TSUYOTOSHI
分类号 A61K35/14;A61K31/00;A61K35/28;A61P37/00;A61P37/02;A61P43/00;(IPC1-7):A61K35/28 主分类号 A61K35/14
代理机构 代理人
主权项
地址
您可能感兴趣的专利